bivalirudin 250 mg/1
bivalirudin · INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION · Slate Run Pharmaceuticals, LLC
No Recall History
Plain English
bivalirudin is a injection, powder, lyophilized, for suspension containing bivalirudin at 250 mg/1, taken intravenous. Manufactured by Slate Run Pharmaceuticals, LLC.
Key Facts
- Brand Name
- bivalirudin
- Generic Name
- bivalirudin
- NDC Code (Product)
70436-025- Manufacturer
- Slate Run Pharmaceuticals, LLC
- Strength
- 250 mg/1
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- ANDA213078
- Drug Class
- Anti-coagulant [EPC]; Direct Thrombin Inhibitor [EPC]
- Marketing Start
- 06/30/2021
Recall History
No Recall HistoryFrequently Asked Questions
What is bivalirudin used for?
bivalirudin contains bivalirudin. It is a injection, powder, lyophilized, for suspension taken intravenous. Consult your doctor for specific uses.
Is bivalirudin a controlled substance?
bivalirudin is not classified as a controlled substance by the DEA.
What is the generic name for bivalirudin?
The generic name for bivalirudin is bivalirudin. There are 10 other brand versions of bivalirudin.
What is the NDC code for bivalirudin 250 mg/1?
The NDC (National Drug Code) for bivalirudin 250 mg/1 is 70436-025, listed by Slate Run Pharmaceuticals, LLC.